This invention relates to a process for making an enantiomer or racemic mixture of a compound of the formula IMAGE wherein R is hydrogen, lower alkyl or a pharmaceutically acceptable, non-toxic salt of a compound wherein R is hydrogen; X is hydrogen, halo, trifluoromethyl, lower alkyl or lower alkoxy, and the wavy lines represent the alpha or beta configuration with the proviso that when one wavy line is a alpha the other is beta ; novel intermediates useful for preparing these compounds; and processes for making the intermediates.
展开▼